BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6182467)

  • 1. Hydroxyurea inhibition of growth and DNA synthesis in Toxoplasma gondii: characterization of a resistant mutant.
    Kasper LH; Pfefferkorn ER
    Mol Biochem Parasitol; 1982 Sep; 6(3):141-50. PubMed ID: 6182467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a mutant of Toxoplasma gondii resistant to aphidicolin.
    Pfefferkorn ER
    J Protozool; 1984 May; 31(2):306-10. PubMed ID: 6206226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of deoxyribonucleoside triphosphate pools induced by hydroxyurea and their relation to DNA synthesis.
    Bianchi V; Pontis E; Reichard P
    J Biol Chem; 1986 Dec; 261(34):16037-42. PubMed ID: 3536919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasma gondii: use of mutants to study the host-parasite relationship.
    Pfefferkorn ER; Schwartzman JD; Kasper LH
    Ciba Found Symp; 1983; 99():74-91. PubMed ID: 6557015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyribonucleoside triphosphate metabolism and the mammalian cell cycle. Effects of hydroxyurea on mutant and wild-type mouse S49 T-lymphoma cells.
    Eriksson S; Skog S; Tribukait B; Wallström B
    Exp Cell Res; 1987 Jan; 168(1):79-88. PubMed ID: 3096753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deoxyribonucleotide metabolism in hydroxyurea-resistant V79 hamster cells.
    Höglund L; Pontis E; Reichard P
    Eur J Biochem; 1991 Feb; 196(1):239-45. PubMed ID: 2001704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoplasma gondii: the biochemical basis of resistance to emimycin.
    Pfefferkorn ER; Eckel ME; McAdams E
    Exp Parasitol; 1989 Aug; 69(2):129-39. PubMed ID: 2526747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arabinosyl nucleosides inhibit Toxoplasma gondii and allow the selection of resistant mutants.
    Pfefferkorn ER; Pfefferkorn LC
    J Parasitol; 1976 Dec; 62(6):993-9. PubMed ID: 1003290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribonucleotide reductase, a possible agent in deoxyribonucleotide pool asymmetries induced by hypoxia.
    Chimploy K; Tassotto ML; Mathews CK
    J Biol Chem; 2000 Dec; 275(50):39267-71. PubMed ID: 11006282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine deoxyribonucleosides counteract effects of hydroxyurea on deoxyribonucleoside triphosphate pools and DNA synthesis.
    Lagergren J; Reichard P
    Biochem Pharmacol; 1987 Sep; 36(18):2985-91. PubMed ID: 3498491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutants of Toxoplasma gondii resistant to atovaquone (566C80) or decoquinate.
    Pfefferkorn ER; Borotz SE; Nothnagel RF
    J Parasitol; 1993 Aug; 79(4):559-64. PubMed ID: 8331476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribonucleotide reductase and thymidine phosphorylation: two potential targets of azodicarbonamide.
    Fagny C; Vandevelde M; Svoboda M; Robberecht P
    Biochem Pharmacol; 2002 Aug; 64(3):451-6. PubMed ID: 12147296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxoplasma gondii: genetic crosses reveal phenotypic suppression of hydroxyurea resistance by fluorodeoxyuridine resistance.
    Pfefferkorn ER; Kasper LH
    Exp Parasitol; 1983 Apr; 55(2):207-18. PubMed ID: 6219892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and initial characterization of a series of Chlamydia trachomatis isolates selected for hydroxyurea resistance by a stepwise procedure.
    Tipples G; McClarty G
    J Bacteriol; 1991 Aug; 173(16):4932-40. PubMed ID: 1860812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of deoxynucleotide metabolism by the deoxycytidylate deaminase inhibitor 3,4,5,6-tetrahydrodeoxyuridine.
    Heinemann V; Plunkett W
    Biochem Pharmacol; 1989 Nov; 38(22):4115-21. PubMed ID: 2688654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant.
    Pfefferkorn ER; Nothnagel RF; Borotz SE
    Antimicrob Agents Chemother; 1992 May; 36(5):1091-6. PubMed ID: 1510399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromodeoxyuridine mutagenesis, ribonucleotide reductase activity, and deoxyribonucleotide pools in hydroxyurea-resistant mutants.
    Ashman CR; Reddy GP; Davidson RL
    Somatic Cell Genet; 1981 Nov; 7(6):751-68. PubMed ID: 7034251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human diploid fibroblasts with alterations in ribonucleotide reductase activity, deoxyribonucleotide pools and in vitro lifespan.
    Dick JE; Wright JA
    Mech Ageing Dev; 1984 Jul; 26(1):37-49. PubMed ID: 6379327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea inhibits intracellular Toxoplasma gondii multiplication.
    de Melo EJ; Mayerhoffer RO; de Souza W
    FEMS Microbiol Lett; 2000 Apr; 185(1):79-82. PubMed ID: 10731610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasma gondii: in vivo and in vitro studies of a mutant resistant to arprinocid-N-oxide.
    Pfefferkorn ER; Eckel ME; McAdams E
    Exp Parasitol; 1988 Apr; 65(2):282-9. PubMed ID: 3350108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.